Dong OM, Friede K, Chanfreau C, Voora D. Cost-effectiveness of CYP2C19-guided de-escalation and escalation of P2Y12 inhibitors in veterans undergoing percutaneous coronary intervention. Presented at the PMLS Virtual Series - RTP/Population Health Meeting; October 21, 2020.


Abstract not available at this time.

Share on: